Predicting risk for new-onset type 2 diabetes in Chinese people with coronary heart disease and impaired glucose tolerance
Asıl Yazarlar: | Xu, S, Scott, C, Coleman, RL, Tuomilehto, J, Holman, RR |
---|---|
Materyal Türü: | Conference item |
Dil: | English |
Baskı/Yayın Bilgisi: |
Springer Nature
2019
|
Benzer Materyaller
-
Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance
Yazar:: Xu, S, ve diğerleri
Baskı/Yayın Bilgisi: (2021) -
Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: insights from the Acarbose Cardiovascular Evaluation (ACE) trial
Yazar:: Wamil, M, ve diğerleri
Baskı/Yayın Bilgisi: (2020) -
Health utilities in Chinese patients with coronary heart disease and impaired glucose tolerance (ACE): a longitudinal analysis of a randomized, double-blind, placebo-controlled trial
Yazar:: Leal, J, ve diğerleri
Baskı/Yayın Bilgisi: (2022) -
Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
Yazar:: Holman, R, ve diğerleri
Baskı/Yayın Bilgisi: (2017) -
Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.
Yazar:: Currie, G, ve diğerleri
Baskı/Yayın Bilgisi: (2017)